financetom
Business
financetom
/
Business
/
Phreesia Fiscal Q1 Net Loss Narrows, Revenue Increases; Lowers Fiscal 2025 Revenue Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Phreesia Fiscal Q1 Net Loss Narrows, Revenue Increases; Lowers Fiscal 2025 Revenue Outlook
May 30, 2024 1:33 PM

04:15 PM EDT, 05/30/2024 (MT Newswires) -- Phreesia ( PHR ) reported a fiscal Q1 net loss Thursday of $0.35 per diluted share, narrowing from $0.70 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.50.

Revenue in the quarter ended April 30 rose to $101.2 million from $83.8 million a year earlier. Analysts surveyed by Capital IQ expected $101 million.

The company lowered its revenue outlook for fiscal 2025 to the range of $416 million to $426 million from $424 million to $434 million. Analysts polled by Capital IQ expected $427.9 million.

Price: 21.31, Change: -0.01, Percent Change: -0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Electra Battery Materials Gets $20 Million Defense Department Award; Shares Jump
Electra Battery Materials Gets $20 Million Defense Department Award; Shares Jump
Aug 19, 2024
02:23 PM EDT, 08/19/2024 (MT Newswires) -- Electra Battery Materials ( ELBM ) received a $20 million award from the US Department of Defense to complete an industrial-scale hydrometallurgical plant and produce cobalt sulfate at its Ontario facility, the Department of Defense said Monday. The funding aims to establish the first North American refinery for cobalt sulfate production, with the...
Genmab, AbbVie Get Conditional European Commission Approval for Lymphoma Treatment
Genmab, AbbVie Get Conditional European Commission Approval for Lymphoma Treatment
Aug 19, 2024
02:41 PM EDT, 08/19/2024 (MT Newswires) -- Genmab ( GMAB ) said Monday that the European Commission granted conditional approval for Tepkinly, or epcoritamab, for the treatment of adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy. Tepkinly, codeveloped with AbbVie ( ABBV ) , is approved for the treatment of relapsed or refractory...
Update: UAW Workers at Stellantis Prepare Grievances, Paving Way for Possible Strike
Update: UAW Workers at Stellantis Prepare Grievances, Paving Way for Possible Strike
Aug 19, 2024
02:31 PM EDT, 08/19/2024 (MT Newswires) -- (Updates with details throughout) Several United Auto Workers union locals representing thousands of Stellantis ( STLA ) workers are prepared to file grievances, alleging the automaker failed to honor its investment commitments and the union contract, setting the stage for a possible national strike at the automaker, the UAW said Monday. According to...
Kroger sues FTC, calling its in-house judges unconstitutional
Kroger sues FTC, calling its in-house judges unconstitutional
Aug 19, 2024
Aug 19 (Reuters) - Kroger ( KR ) sued the U.S. Federal Trade Commission on Monday, seeking to block the regulator from reviewing the grocery chain's proposed $25 billion merger with smaller rival Albertsons ( ACI ), calling the FTC's in-house tribunal unconstitutional. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved